Cargando…
Natural compound Tan-I enhances the efficacy of Paclitaxel chemotherapy in ovarian cancer
BACKGROUND: Paclitaxel is a widely used clinical first line chemotherapy drug for ovarian carcinoma. Tanshinone I (Tan-I) is one of the vital fat-soluble components, which derived from Chinese herbal medicine, Salvia miltiorrhiza Bunge. Herein, we evaluated whether Tan-I could enhance the efficacy o...
Autores principales: | Zhou, Jin, Jiang, Yuan-Yuan, Wang, Hai-Ping, Chen, Huan, Wu, Yi-Chao, Wang, Long, Pu, Xiang, Yue, Guizhou, Zhang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333144/ https://www.ncbi.nlm.nih.gov/pubmed/32647677 http://dx.doi.org/10.21037/atm-20-4072 |
Ejemplares similares
-
Tanshinone IIA suppresses ovarian cancer growth through inhibiting malignant properties and angiogenesis
por: Zhou, Jin, et al.
Publicado: (2020) -
Efficacy evaluation of albumin-bound paclitaxel combined with carboplatin as neoadjuvant chemotherapy for primary epithelial ovarian cancer
por: Wang, Huan, et al.
Publicado: (2022) -
NMR Evidence for the Topologically Nontrivial Nature in a Family of Half-Heusler Compounds
por: Zhang, Xiaoming, et al.
Publicado: (2016) -
Phase I study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer
por: Broekman, K. Esther, et al.
Publicado: (2020) -
A colorimetric comparison of sunless with natural skin tan
por: Amano, Kinjiro, et al.
Publicado: (2020)